Literature DB >> 16043640

Plasma oxidized low-density lipoprotein, a strong predictor for acute coronary heart disease events in apparently healthy, middle-aged men from the general population.

Christa Meisinger1, Jens Baumert, Natalie Khuseyinova, Hannelore Loewel, Wolfgang Koenig.   

Abstract

BACKGROUND: Oxidized LDL (oxLDL) is thought to play a key role in the inflammatory response in the arterial vessel wall. METHODS AND
RESULTS: In a prospective, nested, case-control study, the association between plasma oxLDL and risk of an acute coronary heart disease (CHD) event was investigated in men without prevalent CHD or diabetes mellitus at baseline. Subjects came from 2 population-based MONICA/KORA Augsburg surveys conducted in the years 1989-1990 and 1994-1995 with follow-up in 1998 (mean+/-SD follow-up time, 5.6+/-2.6 years). OxLDL was determined by ELISA in 88 men with incident CHD and in 258 age- and survey-matched controls. Hazard ratios (HRs) were estimated from conditional logistic-regression models with matching for age and survey. Baseline mean plasma oxLDL concentrations were significantly higher in subjects who subsequently experienced an event compared with controls (mean+/-SD, 110+/-32 versus 93+/-28 U/L; P< or =0.001). After adjustment for smoking, hypertension, obesity, physical activity, education, and alcohol consumption, the HR for a future CHD event in a comparison of the upper tertile of the oxLDL distribution with the lower tertile was 4.25 (95% confidence interval, 2.09 to 8.63; P<0.001). Plasma oxLDL was the strongest predictor of CHD events compared with a conventional lipoprotein profile and other traditional risk factors for CHD. When both oxLDL and C-reactive protein were simultaneously assessed in the same model, they still predicted future CHD events even after multivariable adjustment.
CONCLUSIONS: Elevated concentrations of oxLDL are predictive of future CHD events in apparently healthy men. Thus, oxLDL may represent a promising risk marker for clinical CHD complications and should be evaluated in further studies.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16043640     DOI: 10.1161/CIRCULATIONAHA.104.529297

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  103 in total

1.  Is there a relationship between serum ox-LDL, oxidative stress, and PON1 in knee osteoarthritis?

Authors:  Cemil Ertürk; Mehmet Akif Altay; Ali Bilge; Hakim Çelik
Journal:  Clin Rheumatol       Date:  2017-06-19       Impact factor: 2.980

2.  Effect of rosuvastatin on outcomes in chronic haemodialysis patients: baseline data from the AURORA study.

Authors:  Bengt Fellström; Hallvard Holdaas; Alan G Jardine; Helen Rose; Roland Schmieder; Wim Wilpshaar; Faiez Zannad
Journal:  Kidney Blood Press Res       Date:  2007-07-11       Impact factor: 2.687

Review 3.  Oxidized low-density lipoprotein biomarkers in atherosclerosis.

Authors:  Sotirios Tsimikas
Journal:  Curr Atheroscler Rep       Date:  2006-01       Impact factor: 5.113

4.  Targeting oxidized LDL improves insulin sensitivity and immune cell function in obese Rhesus macaques.

Authors:  Shijie Li; Paul Kievit; Anna-Karin Robertson; Ganesh Kolumam; Xiumin Li; Karin von Wachenfeldt; Christine Valfridsson; Sherry Bullens; Ilhem Messaoudi; Lindsay Bader; Kyra J Cowan; Amrita Kamath; Nicholas van Bruggen; Stuart Bunting; Björn Frendéus; Kevin L Grove
Journal:  Mol Metab       Date:  2013-06-11       Impact factor: 7.422

5.  Association Between Oxidation-Modified Lipoproteins and Coronary Plaque in Psoriasis.

Authors:  Alexander V Sorokin; Kazuhiko Kotani; Youssef A Elnabawi; Amit K Dey; Aparna P Sajja; Shingo Yamada; Masashi Ueda; Charlotte L Harrington; Yvonne Baumer; Justin A Rodante; Joel M Gelfand; Marcus Y Chen; Aditya A Joshi; Martin P Playford; Alan T Remaley; Nehal N Mehta
Journal:  Circ Res       Date:  2018-11-09       Impact factor: 17.367

Review 6.  Lipoproteins and fatty acids in chronic kidney disease: molecular and metabolic alterations.

Authors:  Heidi Noels; Michael Lehrke; Raymond Vanholder; Joachim Jankowski
Journal:  Nat Rev Nephrol       Date:  2021-05-10       Impact factor: 28.314

7.  Postpartum weight retention is associated with elevated ratio of oxidized LDL lipids to HDL-cholesterol.

Authors:  Jatta Puhkala; Riitta Luoto; Markku Ahotupa; Jani Raitanen; Tommi Vasankari
Journal:  Lipids       Date:  2013-12       Impact factor: 1.880

8.  Autoantibodies against oxidized low-density lipoprotein and lipid profile in patients with chronic periaortitis: case-control study.

Authors:  E F H van Bommel; L J H van Tits; E A van den Berg; J Prins; A F H Stalenhoef
Journal:  Rheumatol Int       Date:  2009-12-12       Impact factor: 2.631

9.  Cardiovascular prevention in clinical practice (ESC and German guidelines 2007).

Authors:  Helmut Gohlke; Christian Albus; Detlef Bernd Gysan; Harry W Hahmann; Peter Mathes
Journal:  Herz       Date:  2009-02       Impact factor: 1.443

10.  Oxidized low-density lipoprotein and ankle-brachial pressure index in patients with clinically evident peripheral arterial disease.

Authors:  Ruben Miguel Ayzin Rosoky; Nelson Wolosker; Michel Nasser; Antonio Eduardo Zerati; Magnus Gidlund; Pedro Puech-Leão
Journal:  Clinics (Sao Paulo)       Date:  2010-04       Impact factor: 2.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.